Similarly, a PL3-derived linear peptide achieves precise NRP-1 targeting exclusively through uPA-mediated proteolytic cleavage, effectively minimizing off-target accumulation while maintaining tumor penetration capability [42]. Here, NRP1 is linked to neoplasm.